甲状腺癌:美国和俄克拉荷马州的甲状腺癌概述和统计数字。

Munim H Deen, Kaitlin M Burke, Amanda Janitz, Janis Campbell
{"title":"甲状腺癌:美国和俄克拉荷马州的甲状腺癌概述和统计数字。","authors":"Munim H Deen, Kaitlin M Burke, Amanda Janitz, Janis Campbell","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Recent studies have shown an apparent increase in thyroid cancer in the United States. Whether is due to an actual increase or increased screening is disputed. We analyzed thyroid cancer incidence and mortality across age and racial groups in Oklahoma (using data from the Oklahoma Central Cancer Registry) against Surveillance, Epidemiology, and End Results (SEER) program national data - using SEER*Stat software for mortality. In the US and Oklahoma, females had a higher AAIR compared to males, but it was lower in Oklahoma than in the US (Females: US 15.5 per 100,000, OK 10.9 per 100,000; Males: US 5.4 per 100,000, OK 3.8 per 100,000). Overall, five-year relative survival was lower, yet still high, for Oklahoma than in the US (92.1% v. 97.1%). Survival by stage was lower in Oklahoma compared to the United States for localized (97.8% v. 99.8%), regional (92.0% v. 97.0%), and distant (36.6% v. 55.3%) stage cancers.</p>","PeriodicalId":75127,"journal":{"name":"The Journal of the Oklahoma State Medical Association","volume":"109 7-8","pages":"333-338"},"PeriodicalIF":0.0000,"publicationDate":"2016-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5119814/pdf/","citationCount":"0","resultStr":"{\"title\":\"Cancers of the Thyroid: Overview and Statistics in the United States and Oklahoma.\",\"authors\":\"Munim H Deen, Kaitlin M Burke, Amanda Janitz, Janis Campbell\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Recent studies have shown an apparent increase in thyroid cancer in the United States. Whether is due to an actual increase or increased screening is disputed. We analyzed thyroid cancer incidence and mortality across age and racial groups in Oklahoma (using data from the Oklahoma Central Cancer Registry) against Surveillance, Epidemiology, and End Results (SEER) program national data - using SEER*Stat software for mortality. In the US and Oklahoma, females had a higher AAIR compared to males, but it was lower in Oklahoma than in the US (Females: US 15.5 per 100,000, OK 10.9 per 100,000; Males: US 5.4 per 100,000, OK 3.8 per 100,000). Overall, five-year relative survival was lower, yet still high, for Oklahoma than in the US (92.1% v. 97.1%). Survival by stage was lower in Oklahoma compared to the United States for localized (97.8% v. 99.8%), regional (92.0% v. 97.0%), and distant (36.6% v. 55.3%) stage cancers.</p>\",\"PeriodicalId\":75127,\"journal\":{\"name\":\"The Journal of the Oklahoma State Medical Association\",\"volume\":\"109 7-8\",\"pages\":\"333-338\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5119814/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Journal of the Oklahoma State Medical Association\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of the Oklahoma State Medical Association","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

最近的研究表明,美国甲状腺癌的发病率明显上升。究竟是由于实际增长还是由于筛查的增加,目前尚存争议。我们分析了俄克拉荷马州不同年龄和种族群体的甲状腺癌发病率和死亡率(使用俄克拉荷马州中央癌症登记处的数据)与监测、流行病学和最终结果(SEER)计划的全国数据(使用SEER*Stat软件分析死亡率)。在美国和俄克拉荷马州,女性的 AAIR 均高于男性,但俄克拉荷马州低于美国(女性:美国为每 10 万人 15.5 例,俄克拉荷马州为每 10 万人 15.5 例):美国每 10 万人中有 15.5 人,俄克拉荷马州每 10 万人中有 10.9 人;男性每 10 万人中有 5.4 人:美国为每 10 万人 5.4 例,俄克拉荷马州为每 10 万人 3.8 例)。总体而言,俄克拉荷马州的五年相对存活率低于美国,但仍然很高(92.1% 对 97.1%)。与美国相比,俄克拉荷马州局部癌症(97.8% 对 99.8%)、区域癌症(92.0% 对 97.0%)和远处癌症(36.6% 对 55.3%)的分期存活率较低。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Cancers of the Thyroid: Overview and Statistics in the United States and Oklahoma.

Recent studies have shown an apparent increase in thyroid cancer in the United States. Whether is due to an actual increase or increased screening is disputed. We analyzed thyroid cancer incidence and mortality across age and racial groups in Oklahoma (using data from the Oklahoma Central Cancer Registry) against Surveillance, Epidemiology, and End Results (SEER) program national data - using SEER*Stat software for mortality. In the US and Oklahoma, females had a higher AAIR compared to males, but it was lower in Oklahoma than in the US (Females: US 15.5 per 100,000, OK 10.9 per 100,000; Males: US 5.4 per 100,000, OK 3.8 per 100,000). Overall, five-year relative survival was lower, yet still high, for Oklahoma than in the US (92.1% v. 97.1%). Survival by stage was lower in Oklahoma compared to the United States for localized (97.8% v. 99.8%), regional (92.0% v. 97.0%), and distant (36.6% v. 55.3%) stage cancers.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Clinical question: Can virtual reality be an effective adjunctive to conventional treatment in patients with chronic lower back pain? Hospital Admission Rates and Mortality Among Emergency Department Patients with COVID-19 Discharged with Remote Patient Monitoring with or without HO2ME - A Value-Based Approach. Investigation of Geographical Disparities: The Use of An Interpolation Method For Cancer Registry Data. In patients with osteoarthritis, is curcumin, compared to placebo, effective in reducing pain? A Snapshot of Oklahoma's CHR/CHW Workforce: Results from the Region 6 Training Needs Assessment Survey, 2019.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1